Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Phenomenology and epidemiology of impulsive-compulsive behaviours in Parkinson's disease, atypical Parkinsonian disorders and non-Parkinsonian populations.

Maloney EM, Djamshidian A, O'Sullivan SS.

J Neurol Sci. 2017 Mar 15;374:47-52. doi: 10.1016/j.jns.2016.12.058. Epub 2016 Dec 28. Review.

PMID:
28108021
2.

Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies.

Hansen C, Andrade SE, Freiman H, Dublin S, Haffenreffer K, Cooper WO, Cheetham TC, Toh S, Li DK, Raebel MA, Kuntz JL, Perrin N, Rosales AG, Carter S, Pawloski PA, Maloney EM, Graham DJ, Sahin L, Scott PE, Yap J, Davis R.

Pharmacoepidemiol Drug Saf. 2016 Feb;25(2):170-8. doi: 10.1002/pds.3919. Epub 2015 Nov 24.

3.

Nonsteroidal Anti-Inflammatory Drug and Aspirin Use, and Mortality among Critically Ill Pandemic H1N1 Influenza Patients: an Exploratory Analysis.

Epperly H, Vaughn FL, Mosholder AD, Maloney EM, Rubinson L.

Jpn J Infect Dis. 2016 May 20;69(3):248-51. doi: 10.7883/yoken.JJID.2014.577. Epub 2015 Aug 7.

4.

Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals.

Enose-Akahata Y, Abrams A, Massoud R, Bialuk I, Johnson KR, Green PL, Maloney EM, Jacobson S.

Retrovirology. 2013 Feb 13;10:19. doi: 10.1186/1742-4690-10-19.

5.

SAMe treatment prevents the ethanol-induced epigenetic alterations of genes in the Toll-like receptor pathway.

Khachatoorian R, Dawson D, Maloney EM, Wang J, French BA, French SW, French SW.

Exp Mol Pathol. 2013 Feb;94(1):243-6. doi: 10.1016/j.yexmp.2012.09.024. Epub 2012 Oct 6.

6.

Divergent antiviral effects of bioflavonoids on the hepatitis C virus life cycle.

Khachatoorian R, Arumugaswami V, Raychaudhuri S, Yeh GK, Maloney EM, Wang J, Dasgupta A, French SW.

Virology. 2012 Nov 25;433(2):346-55. doi: 10.1016/j.virol.2012.08.029. Epub 2012 Sep 11.

7.

Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.

Enose-Akahata Y, Abrams A, Johnson KR, Maloney EM, Jacobson S.

Blood. 2012 Mar 22;119(12):2829-36. doi: 10.1182/blood-2011-11-390807. Epub 2012 Feb 7.

8.

A cell-permeable hairpin peptide inhibits hepatitis C viral nonstructural protein 5A-mediated translation and virus production.

Khachatoorian R, Arumugaswami V, Ruchala P, Raychaudhuri S, Maloney EM, Miao E, Dasgupta A, French SW.

Hepatology. 2012 Jun;55(6):1662-72. doi: 10.1002/hep.25533. Epub 2012 Jan 30.

9.

Anogenital human papillomavirus in sexually abused and nonabused children: a multicenter study.

Unger ER, Fajman NN, Maloney EM, Onyekwuluje J, Swan DC, Howard L, Beck-Sague CM, Sawyer MK, Girardet RG, Sautter RL, Hammerschlag MR, Black CM.

Pediatrics. 2011 Sep;128(3):e658-65. doi: 10.1542/peds.2010-2247. Epub 2011 Aug 15.

PMID:
21844060
10.

Gynecological history in chronic fatigue syndrome: a population-based case-control study.

Boneva RS, Maloney EM, Lin JM, Jones JF, Wieser F, Nater UM, Heim CM, Reeves WC.

J Womens Health (Larchmt). 2011 Jan;20(1):21-8. doi: 10.1089/jwh.2009.1900. Epub 2010 Nov 20.

11.

Chronic fatigue syndrome is associated with metabolic syndrome: results from a case-control study in Georgia.

Maloney EM, Boneva RS, Lin JM, Reeves WC.

Metabolism. 2010 Sep;59(9):1351-7. doi: 10.1016/j.metabol.2009.12.019. Epub 2010 Jan 27.

PMID:
20102774
12.

Further validation of the Multidimensional Fatigue Inventory in a US adult population sample.

Lin JM, Brimmer DJ, Maloney EM, Nyarko E, Belue R, Reeves WC.

Popul Health Metr. 2009 Dec 15;7:18. doi: 10.1186/1478-7954-7-18.

13.

An evaluation of exclusionary medical/psychiatric conditions in the definition of chronic fatigue syndrome.

Jones JF, Lin JM, Maloney EM, Boneva RS, Nater UM, Unger ER, Reeves WC.

BMC Med. 2009 Oct 12;7:57. doi: 10.1186/1741-7015-7-57.

14.

Use of medications by people with chronic fatigue syndrome and healthy persons: a population-based study of fatiguing illness in Georgia.

Boneva RS, Lin JM, Maloney EM, Jones JF, Reeves WC.

Health Qual Life Outcomes. 2009 Jul 20;7:67. doi: 10.1186/1477-7525-7-67.

15.

Proviral loads and clonal expansion of HTLV-1-infected cells following vertical transmission: a 10-year follow-up of children in Jamaica.

Umeki K, Hisada M, Maloney EM, Hanchard B, Okayama A.

Intervirology. 2009;52(3):115-22. doi: 10.1159/000219384. Epub 2009 May 20.

16.

Psychiatric comorbidity in persons with chronic fatigue syndrome identified from the Georgia population.

Nater UM, Lin JM, Maloney EM, Jones JF, Tian H, Boneva RS, Raison CL, Reeves WC, Heim C.

Psychosom Med. 2009 Jun;71(5):557-65. doi: 10.1097/PSY.0b013e31819ea179. Epub 2009 May 4.

PMID:
19414619
17.

Chronic fatigue syndrome and high allostatic load: results from a population-based case-control study in Georgia.

Maloney EM, Boneva R, Nater UM, Reeves WC.

Psychosom Med. 2009 Jun;71(5):549-56. doi: 10.1097/PSY.0b013e3181a4fea8. Epub 2009 May 4.

PMID:
19414615
18.

An angiotensin-1 converting enzyme polymorphism is associated with allostatic load mediated by C-reactive protein, interleukin-6 and cortisol.

Smith AK, Maloney EM, Falkenberg VR, Dimulescu I, Rajeevan MS.

Psychoneuroendocrinology. 2009 May;34(4):597-606. doi: 10.1016/j.psyneuen.2008.10.022. Epub 2008 Dec 10.

PMID:
19081678
19.

Higher heart rate and reduced heart rate variability persist during sleep in chronic fatigue syndrome: a population-based study.

Boneva RS, Decker MJ, Maloney EM, Lin JM, Jones JF, Helgason HG, Heim CM, Rye DB, Reeves WC.

Auton Neurosci. 2007 Dec 30;137(1-2):94-101. Epub 2007 Sep 12.

PMID:
17851136
20.

Complementary and alternative medical therapy utilization by people with chronic fatiguing illnesses in the United States.

Jones JF, Maloney EM, Boneva RS, Jones AB, Reeves WC.

BMC Complement Altern Med. 2007 Apr 25;7:12.

Supplemental Content

Loading ...
Support Center